StoneX Financial Europe GmbH Partners with Expana to Launch OTC Dairy Derivatives Suite

StoneX Financial Europe collaborates with Expana to enhance dairy derivatives trading, improving risk management and price transparency.

Quiver AI Summary

StoneX Financial Europe GmbH has partnered with Expana to introduce a new suite of over-the-counter (OTC) dairy derivatives based on Expana's IOSCO-assured EU dairy benchmarks. This collaboration aims to provide enhanced risk management tools and improve price transparency in the global dairy industry. The initial contracts will focus on fat-filled milk powder and high-protein whey, with plans to expand to other dairy products later. Users of StoneX Plus will have direct access to Expana's benchmarks, allowing for better hedging and risk management decisions. Spencer Wicks, CEO of Expana, emphasized that this partnership is a significant advancement for the dairy sector, while Liam Fenton from StoneX highlighted the importance of providing reliable benchmarks to address market volatility and support transparent pricing.

Potential Positives

The collaboration with Expana enables StoneX to enhance its offerings in OTC dairy derivatives, providing innovative risk management tools for the global dairy industry.
The use of IOSCO-assured EU dairy benchmarks by Expana adds credibility and transparency to the new suite of products, promoting trust among market participants.
The partnership addresses the growing demand for reliable risk management solutions in the dairy sector, positioning StoneX as a leader in this space.
StoneX Plus will gain direct access to Expana’s benchmark data, which will improve liquidity and support more informed decision-making for clients in the dairy market.

Potential Negatives

The press release highlights a collaboration that may indicate a response to increasing market volatility and risk management needs, suggesting that the company may have faced challenges in these areas that prompted this action.
The reliance on an external partner, Expana, for key benchmarks may raise concerns about dependency and control over critical aspects of the trading and risk management products offered.
While the announcement focuses on expanding services, it does not address any specific financial or operational metrics, leaving stakeholders with unanswered questions regarding the expected impact on the company's performance.

FAQ

What is the new collaboration between StoneX and Expana?

StoneX Financial Europe GmbH has partnered with Expana to launch a suite of OTC dairy derivatives using Expana’s EU dairy benchmarks.

What dairy products will the new contracts cover?

The initial contracts will include fat-filled milk powder and high-protein whey, with plans to add more dairy products in the future.

How does this collaboration impact risk management in the dairy industry?

This partnership enhances price transparency and provides more effective risk management tools for the global dairy sector.

What benefits do StoneX Plus users receive from this collaboration?

StoneX Plus users will gain direct access to Expana’s benchmarks, improving their ability to make informed hedging and risk management decisions.

Who can benefit from Expana's services?

Organizations in the global dairy sector seeking reliable pricing data and insights for better strategic decision-making will benefit from Expana's services.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

$SNEX Insider Trading Activity

$SNEX insiders have traded $SNEX stock on the open market 16 times in the past 6 months. Of those trades, 1 have been purchases and 15 have been sales.

Here’s a breakdown of recent trading of $SNEX stock by insiders over the last 6 months:

PHILIP ANDREW SMITH (Chief Executive Officer) has made 0 purchases and 4 sales selling 59,957 shares for an estimated $4,935,602.
SEAN MICHAEL OCONNOR (Executive Vice-Chairman-Board) has made 0 purchases and 4 sales selling 42,500 shares for an estimated $3,842,324.
ABIGAIL H PERKINS (Chief Information Officer) has made 0 purchases and 3 sales selling 36,680 shares for an estimated $3,123,668.
CHARLES M LYON (President) has made 0 purchases and 2 sales selling 30,000 shares for an estimated $2,624,660.
JOHN MOORE FOWLER has made 0 purchases and 2 sales selling 2,250 shares for an estimated $206,718.
JOHN RADZIWILL (Chairman of the Board) purchased 1,400 shares for an estimated $119,000

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$SNEX Hedge Fund Activity

We have seen 174 institutional investors add shares of $SNEX stock to their portfolio, and 128 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

ROCKEFELLER CAPITAL MANAGEMENT L.P. removed 846,674 shares (-95.2%) from their portfolio in Q2 2025, for an estimated $77,165,868
PRICE T ROWE ASSOCIATES INC /MD/ added 610,928 shares (+77.2%) to their portfolio in Q2 2025, for an estimated $55,679,977
AMERICAN CENTURY COMPANIES INC added 389,132 shares (+19.8%) to their portfolio in Q2 2025, for an estimated $35,465,490
GOLDENTREE ASSET MANAGEMENT LP added 357,152 shares (+inf%) to their portfolio in Q2 2025, for an estimated $32,550,833
DIMENSIONAL FUND ADVISORS LP removed 274,331 shares (-14.3%) from their portfolio in Q2 2025, for an estimated $25,002,527
JPMORGAN CHASE & CO added 256,081 shares (+71.9%) to their portfolio in Q2 2025, for an estimated $23,339,222
VAN BERKOM & ASSOCIATES INC. removed 211,684 shares (-15.0%) from their portfolio in Q2 2025, for an estimated $19,292,879

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Full Release

HAMBURG, Germany, Oct. 07, 2025 (GLOBE NEWSWIRE) -- StoneX Financial Europe GmbH (“SFEG”), a subsidiary of StoneX Group Inc. (“StoneX”; NASDAQ: SNEX), has announced a collaboration with Expana to launch a new suite of OTC dairy derivatives referencing Expana’s IOSCO-assured EU dairy benchmarks. The partnership expands the range of risk management tools available to the global dairy industry and enhances price transparency.

The first contracts will cover fat-filled milk powder and high-protein whey, with plans to broaden coverage to additional dairy products over time. StoneX Plus users will gain direct access to Expana’s benchmarks within their trading workflow, enabling market participants to make more informed hedging and risk management decisions.

“This collaboration with StoneX marks a major milestone for the dairy industry. By combining Expana’s independent IOSCO-assured benchmarks with StoneX’s unmatched leadership in OTC and futures dairy markets, we are building the tools that will underpin more effective and transparent dairy risk management for years to come,” said Spencer Wicks, CEO of Expana.

“Our clients in the global dairy sector are increasingly looking for new ways to manage risk and respond to market volatility,” said Liam Fenton, Global Head of Dairy & Food Group, StoneX. “By working with Expana, we are giving them access to reliable, independent benchmarks that will help improve liquidity, support more transparent pricing, and ultimately strengthen risk management across the industry.”

About StoneX

A Fortune 50 company headquartered in New York City and listed on the Nasdaq Global Select Market (NASDAQ: SNEX), StoneX Group Inc. and its more than 4,700 employees serve over 54,000 commercial, institutional, and payments clients, as well as more than 400,000 retail accounts, across more than 80 offices on six continents. Further information is available at www.stonex.com .

About Expana

Expana is the world’s leading agrifood-focused price reporting agency and global information provider, enabling organizations to make smarter strategic decisions. In markets defined by volatility, opacity, and risk, Expana equips organizations with the foresight to know when to buy or sell, how much, where to source, what to reformulate, and how to price. By uniting frequently updated pricing data, predictive forecasts, cost modeling, and expert analysis, Expana transforms market data into negotiation power and boardroom-ready intelligence. For more information, visit https://www.expanamarkets.com/product/expana-platform/ .

SNEX-G